Digital Diabetes Management Market to Reach US$ 29.6 Billion, Globally, by 2027 at 22.6% CAGR | Exclusive Report by IMARC Group

Digital Diabetes Management Market to Reach US$ 29.6 Billion, Globally, by 2027 at 22.6% CAGR | Exclusive Report by IMARC Group
Digital Diabetes Management Market Research Report 2022-2027
Digital diabetes management solutions and advanced devices segment accounted for the largest share in the Digital Diabetes Management market

According to the latest report by IMARC Group, titled “Digital Diabetes Management Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global digital diabetes management market size reached US$ 8.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 29.6 Billion by 2027, exhibiting a growth rate (CAGR) of 22.6% during 2022-2027.

What is digital diabetes management?

Digital diabetes management is an electronic medical solution that uses software-based applications and devices, such as insulin pens, smart glucose meters, closed-loop systems, sensors, and insulin patches. They are largely used for remote monitoring, management, and analysis of patients with diabetes.

Digital Diabetes Management Industry Overview:

Diabetes, a metabolic disorder, affects insulin production and leads to elevated blood sugar levels in the body. Digital diabetes management helps manage hyper/hypotension, cholesterol levels, and blood glucose and effectively track and maintain the record of the patients. As a result, they are witnessing a significant demand across at-home or self-care facilities, clinics, hospitals, and research institutes.

Request to get the sample report:

Why is digital diabetes management becoming popular?

Increasing health consciousness among consumers and the rising product recognition among the masses are  accelerating the market growth

The market is primarily driven by the rising prevalence of obesity and diabetes across the globe due to sedentary lifestyles, busy schedules, and genetic and environmental factors. Digital diabetes management devices, such as smart insulin pens, are gaining popularity among diabetic patients as they can record the dosage amount and transmit the related data to a cloud-based application to keep a record and use for future reference. In addition to this, key manufacturers are integrating connected devices with the Internet of Things (IoT), big data solutions, and artificial intelligence (AI) to introduce advanced solutions, which is creating a positive outlook for the market.

Digital Diabetes Management Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the digital diabetes management market has been studied in the report with the detailed profiles of the key players operating in the market.

Who are some of the Top Manufacture operating in the digital diabetes management devices and how high is the competition 2022?

  • Abbott Laboratories (NYSE: ABT)
  • ACON Laboratories Inc
  • Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
  • Becton, Dickinson and Company (NYSE: BDX)
  • Dexcom Inc. (NASDAQ: DXCM)
  • Hoffmann-La Roche AG
  • Medtronic plc (NYSE: MDT)
  • Novo Nordisk A/S (NYSE: NVO)
  • Tandem Diabetes Care Inc. (NASDAQ: TNDM)
  • Terumo Corporation (OTCMKTS: TRUMY)

Key Market Segmentation:

The report has segmented the global digital diabetes management market on the basis of product type, device type and region.

Breakup by Product Type:

  • Smart Glucose Meter
  • Smart Insulin Pumps
  • Smart Insulin Pens
  • Apps

Breakup by Device Type:

  • Handheld Devices
  • Wearable Devices

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Explore Report Description with TOC & List of Figure:


Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.


Browse More Related Reports: 

Spain Diabetes Market Reserach Report

Diabetic Retinopathy Market Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026: The rising geriatric population and increasing numbers of diabetic individuals are primarily driving the growth of the diabetic retinopathy market.


About US:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:IMARC Group

30 N Gould St, Ste R

Sheridan, WY 82801,USA



Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States